ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+6.42%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$4.21B
AUM Growth
+$290M
(+7.4%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
1,462
New
252
Increased
614
Reduced
435
Closed
141
Top Buys
| 1 |
NVIDIA
NVDA
|
+$37.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$30.2M |
| 3 |
Verizon
VZ
|
+$29.5M |
| 4 |
Microsoft
MSFT
|
+$21.8M |
| 5 |
Gilead Sciences
GILD
|
+$19.8M |
Top Sells
| 1 |
Tesla
TSLA
|
+$19.4M |
| 2 |
AbbVie
ABBV
|
+$19.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$17.8M |
| 4 |
ServiceNow
NOW
|
+$15.8M |
| 5 |
Roblox
RBLX
|
+$13.4M |
Sector Composition
| 1 | Technology | 21.58% |
| 2 | Energy | 13.05% |
| 3 | Healthcare | 8.58% |
| 4 | Financials | 8.4% |
| 5 | Communication Services | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
HUTCHMED
HCM
$2.7B
| $198K | ﹤0.01% |
10,131
-2,820
| -22% | -$55.1K |
|
977
Tyra Biosciences
TYRA
$635M
| $195K | ﹤0.01% |
8,311
-3,934
| -32% | -$92.5K |
|
978
Weatherford International
WFRD
$4.58B
| $192K | ﹤0.01% |
2,260
-149
| -6% | -$12.7K |
|
979
Enliven Therapeutics
ELVN
$1.14B
| $191K | ﹤0.01% |
7,483
-11,350
| -60% | -$290K |
|
980
Waters Corp
WAT
$17.4B
| $191K | ﹤0.01% |
531
-2,568
| -83% | -$924K |
|
981
Wabtec
WAB
$32.4B
| $189K | ﹤0.01% |
1,041
+994
| +2,115% | +$181K |
|
|
BORR
982
Borr Drilling
BORR
$884M
| $188K | ﹤0.01% |
34,268
-3,881
| -10% | -$21.3K |
|
|
BPMC
983
DELISTED
Blueprint Medicines
BPMC
| $188K | ﹤0.01% |
2,031
-505
| -20% | -$46.7K |
|
984
Lyell Immunopharma
LYEL
$251M
| $186K | ﹤0.01% |
6,753
+1,836
| +37% | +$50.7K |
|
985
Bio-Techne
TECH
$7.93B
| $185K | ﹤0.01% |
+2,318
| New | +$185K |
|
986
Watts Water Technologies
WTS
$9.29B
| $184K | ﹤0.01% |
887
-4,570
| -84% | -$947K |
|
987
Arcellx
ACLX
$4.03B
| $182K | ﹤0.01% |
2,175
-950
| -30% | -$79.3K |
|
988
Karyopharm Therapeutics
KPTI
$53.8M
| $182K | ﹤0.01% |
14,586
+3,774
| +35% | +$47K |
|
989
Compass Therapeutics
CMPX
$604M
| $180K | ﹤0.01% |
97,931
-14,089
| -13% | -$25.9K |
|
990
Apollomics
APLM
$6.83M
| $179K | ﹤0.01% |
12,591
+8,963
| +247% | +$127K |
|
991
RAPT Therapeutics
RAPT
$234M
| $179K | ﹤0.01% |
11,135
+7,905
| +245% | +$127K |
|
992
Blackstone
BX
$139B
| $179K | ﹤0.01% |
1,167
+1,116
| +2,188% | +$171K |
|
993
ImmunityBio
IBRX
$2.43B
| $179K | ﹤0.01% |
47,984
+3,722
| +8% | +$13.8K |
|
994
Accenture
ACN
$151B
| $178K | ﹤0.01% |
504
-5,965
| -92% | -$2.11M |
|
995
Hartford Financial Services
HIG
$36.9B
| $178K | ﹤0.01% |
+1,512
| New | +$178K |
|
|
IPHA
996
Innate Pharma
IPHA
$190M
| $177K | ﹤0.01% |
77,350
-8,887
| -10% | -$20.4K |
|
997
Syndax Pharmaceuticals
SNDX
$1.36B
| $177K | ﹤0.01% |
9,201
-394
| -4% | -$7.58K |
|
998
LKQ Corp
LKQ
$8.26B
| $177K | ﹤0.01% |
+4,429
| New | +$177K |
|
999
Replimune Group
REPL
$468M
| $175K | ﹤0.01% |
16,010
-8,574
| -35% | -$94K |
|
|
IGMS
1000
DELISTED
IGM Biosciences
IGMS
| $175K | ﹤0.01% |
10,572
-10,735
| -50% | -$178K |
|